Basit öğe kaydını göster

dc.contributor.authorYuksel, Husniye
dc.contributor.authorAdemoglu, Evin
dc.contributor.authorKaya, Aysem
dc.contributor.authorCoban, Neslihan
dc.contributor.authorOnat, Altan
dc.contributor.authorCan, Gunay
dc.date.accessioned2021-03-03T09:32:33Z
dc.date.available2021-03-03T09:32:33Z
dc.date.issued2017
dc.identifier.citationOnat A., Ademoglu E., Can G., Coban N., Kaya A., Yuksel H., "Lower circulating migration inhibitory factor protein is associated with metabolic syndrome and diabetes", BIOMARKERS IN MEDICINE, cilt.11, sa.7, ss.557-568, 2017
dc.identifier.issn1752-0363
dc.identifier.othervv_1032021
dc.identifier.otherav_1d850eb9-f613-4fae-8d9b-e10527c829bb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/25027
dc.identifier.urihttps://doi.org/10.2217/bmm-2016-0359
dc.description.abstractAim: The controversial relationship between macrophage migration inhibitory factor (MIF) and the likelihood of cardiometabolic diseases was investigated. Results/methodology: Assayed MIF protein from 1225 adults was cross-sectionally analyzed. MIF was independently inversely associated with age, total testosterone and positively with high-density lipoprotein-cholesterol. In men MIF correlation with age, testosterone and waist circumference converted from inverse in the upper to positive in the bottom MIF third. Both metabolic syndrome and diabetes were significantly associated, in combined gender, with the intermediate (vs the highest) MIF tertile at an odds ratio 1.6. Coronary heart disease was not significantly related with MIF in either gender. Discussion/conclusion: Findings are consistent with oxidative damage to MIF protein and its involvement in autoimmune activation, likely more extensive in women.
dc.language.isoeng
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.titleLower circulating migration inhibitory factor protein is associated with metabolic syndrome and diabetes
dc.typeMakale
dc.relation.journalBIOMARKERS IN MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume11
dc.identifier.issue7
dc.identifier.startpage557
dc.identifier.endpage568
dc.contributor.firstauthorID79


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster